Latest filing published 28 Dec 2012 for IMMUNE PHARMACEUTICALS INC.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Stephane Allard: trading record in brief
Stephane Allard discloses dealings in Immune Pharmaceuticals Inc to SEC (Form 4). In total, 5 filings cover trades dated from 13 September 2007 to 27 December 2012.
No open-market sale appears; the market trades are 4 purchases worth €44k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 option exercise.
A typical purchase (the median) is worth €5,659.
The latest filing, published on 28 December 2012, reports an option exercise in Immune Pharmaceuticals Inc. The latest purchase dates back some time: it was published 6,906 days ago, on 13 December 2007. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Stephane Allard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 350,000 shares0Common StockSEC:0001208261-12-000011:0
- 600 shares@ US$1.62Common Stock, par value $0.0001SEC:0000909518-07-001070:0Canonical exit: 12 Dec 2007 (T+90)
- 33,200 shares@ US$1.43Common Stock, par value $0.0001SEC:0000909518-07-001070:1Canonical exit: 10 Mar 2008 (T+90)
- 1,800 shares@ US$1.42Common Stock, par value $0.0001SEC:0000909518-07-001070:2Canonical exit: 11 Mar 2008 (T+90)
- 10,000 shares@ US$1.41Common Stock, par value $0.0001SEC:0000909518-07-001070:3Canonical exit: 11 Mar 2008 (T+90)
5 of 5 declarations